PREVIEW EDITION

Start your 14-day free trial for unlimited access to Axios Pro.

Smart Brevity™ count: 187 words, 1 minute.
Unlock full access or forward to a colleague.

Scoop: Health automation company Olive AI is shutting down

This scoop was exclusively broken by Axios Pro Health Tech deals reporter Erin Brodwin.

Once-buzzy AI startup Olive is selling the remainder of its assets and winding down operations, per two memos viewed by Axios.

Why it matters: It marks the final nail in the coffin for Olive, whose purple "go save health care" buses once dominated industry conferences.

Details: Based in Columbus, Ohio, Olive sold its remaining business lines to health care companies Waystar and Humata Health and, per a memo, "will wind down the remainder of its business."

Check out Erin's previous coverage of Olive AI:

Read the full story

Today's Top Deals

Fintech: Animoca Brands, a Web3 gaming company, is raising $25m in convertible notes from Saudi Arabia's NEOM megaproject. NEOM is also buying $25m in secondaries. View all 4 deals.
SkyCell, a Swiss developer of medicine and vaccine transportation containers, raised $57m at a $600m valuation led by Catalyst. View all 7 deals.
Climate: Samara, an SF-based maker of tiny homes, raised $41m. Thrive Capital led, and was joined by 8VC, General Catalyst, New Legacy, Ron Conway's SV Angel, and Airbnb. View all 13 deals.
Media: KKR completed its $1.62b all-cash acquisition of book publisher Simon & Schuster from Paramount Global (Nasdaq: PARA). View all 3 deals.
Retail: Clariant, a Swiss chemicals company, has agreed to acquire Lucas Meyer Cosmetics from International Fragrance and Flavors for $810m. View all 2 deals.

🔎 Analyze all of today's deals with Deals Tracker, our AI-powered research tool.

Analyze today's deals

Today's top stories

Fintech ○ Health Tech ○ Retail ○ Media ○ Climate

Exclusive: Neuros Medical gets $25M to relieve post-amputation pain

Exclusive: ESG Flo raises $5.25M to automate data gathering

QI Tech bags $200 million with eye on M&A

Money20/20 state of dealmaking: Points for creativity

This is just a small fraction of today's Axios Pro reporting. Start your free trial to unlock daily newsletters, exclusive events, Deals Tracker and more.